Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks

European Journal of Nuclear Medicine

Volumn 29, Issue 11, 2002, Pages 1447-1454

  Varrone, Andrea ^a,b,c,d   Pappatà, Sabina ^a,b,c,d   Caracò, Corradina ^a,b,c,d   Soricelli, Andrea ^a,b,c,d   Milan, Graziella ^a,b,c,d   Quarantelli, Mario ^a,b,c,d   Alfano, Bruno ^a,b,c,d   Postiglione, Alfredo ^a,b,c,d   Salvatore, Marco ^a,b,c,d  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^c Piano Lago di Mangone   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Alzheimer's disease; Cerebral perfusion; Frontotemporal dementia; SPET; Statistical parametric mapping

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; EMOTION; FEMALE; FRONTAL CORTEX; FRONTOTEMPORAL DEMENTIA; HUMAN; IMAGE ANALYSIS; MALE; NERVE CELL NETWORK; OCCIPITAL CORTEX; ORBITAL CORTEX; PARIETAL LOBE; PREFRONTAL CORTEX; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL PARAMETERS; TEMPORAL CORTEX; BRAIN CIRCULATION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED CLINICAL TRIAL; DEMENTIA; IMAGE SUBTRACTION; METHODOLOGY; PATHOPHYSIOLOGY; SCINTISCANNING; THREE DIMENSIONAL IMAGING; VASCULARIZATION;

AGED; ALZHEIMER DISEASE; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DEMENTIA; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; NERVE NET; RADIOPHARMACEUTICALS; SUBTRACTION TECHNIQUE; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036033630     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0883-5     Document Type: Article

References (46)

1. Francis PT, Holmes C, Webster MT, Stratmann GC, Procter AW, Bowen DM. Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy. Dementia 1993; 4:172-177.
2. Procter AW, Qurne M, Francis PT. Neurochemical features of frontotemporal dementia. Dement Geriatr Cogn Disord 1999; 10 (Suppl 1):80-84.
3. Litvan I. Therapy and management of frontal lobe dementia patients. Neurology 2001; 56:S41-S45.
4. Miller BL, Ikonte C, Ponton M, Levy M, Boone K, Darby A, Berman N, Mena I, Cummings JL. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology 1997; 48:937-942.
5. Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 2000; 55:1613-1620.
6. Siri S, Benaglio I, Frigerio A, Binetti G, Cappa SF. A brief neuropsychological assessment for the differential diagnosis between frontotemporal dementia and Alzheimer's disease. Eur J Neurol 2001; 8:125-132.
7. Starkstein SE, Migliorelli R, Tesón A, Sabe L, Vázquez S, Turjanski M, Robinson RG, Leiguarda R. Specificity of changes in cerebral blood flow in patients with frontal lobe dementia. J Neurol Neurosurg Psychiatry 1994; 57:790-796.
8. 99mTc-HMPAO SPECT in the investigation of dementia? J Neurol Neurosurg Psychiatry 1998; 64:306-313.
9. Duara R, Barker W, Luis CA. Frontotemporal dementia and Alzheimer's disease: differential diagnosis. Dement Geriatr Cogn Disord 1999; 10 (Suppl 1):37-42.
10. Sjogren M, Gustafson L, Wikkelso C, Wallin A. Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio. Dement Geriatr Cogn Disord 2000; 11:275-285.
11. 99mTc HmPAO SPECT data. J Neurol Neurosurg Psychiatry 2000; 69:661-663.
12. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A. The scintigraphic appearance of Alzheimer's disease: A prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992; 33:181-185.
13. 99mTc]-d,l-HMPAO SPECT study. J Neurol Neurosurg Psychiatry 1994; 57:285-295.
14. Julin P, Wahlund LO, Basun H, Persson A, Mare K, Rudberg U. Clinical diagnosis of frontal lobe dementia and Alzheimer's disease: Relation to cerebral perfusion, brain atrophy and electroencephalography. Dementia 1995; 6:142-147.
15. Ishii K, Sakamoto S, Sasaki M, Kitagaki H, Yamaji S, Hashimoto M, Imamaura T, Shimomura T, Hirono N, Mori E. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 1998; 39:1875-1878.
16. Acton PD, Friston KJ. Statistical parametric mapping in functional neuroimaging: Beyond PET and fMRI activation studies. Eur J Nucl Med 1998; 25:663-667.
17. Imran MB, Kawashima R, Awata S, Sato K, Kinomura S, Ono S, Yoshioka S, Sato M, Fukuda H. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: A SPECT study using HMPAO and image standardization technique. J Nucl Med 1999; 40:244-249.
18. Holmes A, Poline JB, Friston KJ. Characterising brain images with the general linear model. In: Frackowiak RSJ, ed.Human brain function. San Diego: Academic Press, 1997:59-84.
19. Garraux G, Salmon E, Degueldre C, Lemaire C, Laureys S, Franck G. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia. Neuroimage 1999; 10:149-162.
20. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester groups. J Neurol Neurosurg Psychiatry 1994; 57:416-418.
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer;s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
22. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; 25:638-643.
23. Pickut BA, Saerens J, Mariën P, Borggreve F, Goeman J, Vandevivere J, Vervaet A, Dierckx R, de Deyn PP. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type. J Nucl Med 1997; 38:929-934.
24. 15O positron emission tomography. Eur J Nucl Med 1997; 24:670-673.
25. Salmon E, Van der Linden MV, Franck G. Anterior cingulate and motor network metabolic impairment in progressive supranuclear palsy. Neuroimage 1997; 5:173-178.
26. Salmon E, Collette F, Degueldre C, Lemaire C, Franck G. Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease. Hum Brain Mapping 2000; 10:39-48.
27. Pagani M, Salmaso D, Ramstrom C, Jonsson C, Lundqvist R, Thurfjell L, Schnell PD, Wagner A, Jacobsson H, Larsson SA. Mapping pathological (99m)Tc-d,l-hexamethylpropylene amine oxime uptake in Alzheimer's disease and frontal lobe dementia with SPECT. Dement Geriatr Cogn Disord 2001; 12: 177-184.
28. Mann DM, South PW, Snowden JS, Neary D. Dementia of frontal lobe type: Neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry 1993; 56:605-614.
29. Sarazin M, Pillon B, Giannakopoulos P, Rancurel G, Samson Y, Dubois B. Clinicometabolic dissociation of cognitive functions and social behavior in frontal lobe lesions. Neurology 1998; 51:142-148.
30. Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behaviour. Brain 1995; 118:279-306.
31. Silberman EK, Weingartner H. Hemispheric lateralization of functions related to emotion. Brain Cogn 1986; 5:322-353.
32. Kawasaki H, Kaufman O, Damasio H, Damasio AR, Granner M, Bakken H, Hori T, Howard MA III, Adolphs R. Single-neuron responses to emotional visual stimuli recorded in human ventral prefrontal cortex. Nat Neurosci 2001; 4:15-16.
33. Mychack P, Kramer JH, Boone KB, Miller BL. The influence of right frontotemporal dysfunction on social behavior in frontotemporal dementia. Neurology 2001; 56:S11-S15.
34. Bonte FJ, Hom J, Tintner R, Weiner MF. Single photon tomography in Alzheimer's disease and the dementias. Semin Nucl Med 1990; 20:342-352.
35. O'Brien JT, Eagger S, Syed GM, Sahakian BJ, Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992; 55:1182-1187.
36. 99mTc-HMPAO SPECT. Neuroradiology 1994; 36:1-6.
37. Osimani A, Ichise M, Chung DG, Pogue JM, Freedman M. SPECT for differential diagnosis of dementia and correlation of rCBF with cognitive impairment. Can J Neurol Sci 1994; 21:104-111.
38. Baron JC, Chetelat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, Eustache F. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001; 14:298-309.
39. Ebmeier KP, Glabus MF, Prentice N, Ryman A, Goodwin GM. A voxel-based analysis of cerebral perfusion in dementia and depression of old age. Neuroimage 1998; 7:199-208.
40. Bouilleret V, Dupont S, Spelle L, Baulac M, Samson Y, Semah F. Insular cortex involvement in mesiotemporal lobe epilepsy: A positron emission tomography study. Ann Neurol 2002; 51:202-208.
41. Talbot PR, Lloyd JJ, Snowden JS, Neary D, Testa HJ. Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia. Eur J Nucl Med 1994; 21:503-508.
42. Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matsuda K, Mori E. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med 1997; 38:925-928.
43. Frisoni G, Beltramello A, Geroldi C, Weiss C, Bianchetti A, Trabucchi M. Brain atrophy in frontotemporal dementia. J Neurol Neurosurg Psychiatry 1996; 61:157-165.
44. Kitagaki H, Mori E, Yamaji S, Ishii K, Hirono N, Kobashi S, Hata Y. Frontotemporal dementia and Alzheimer disease: Evaluation of cortical atrophy with automated hemispheric surface display generated with MR images. Radiology 1998; 208: 431-439.
45. Hodges J. Frontotemporal dementia (Pick's disease): Clinical features and assessment. Neurology 2001; 56:S6-S10.
46. 18F]FDG PET: A clinical validation of statistical parametric mapping.Neuroimage 1999; 9:63-80.